معرفی
Jane Skok is the Sandra and Edward H. Meyer Professor of Radiation Oncology in the Department of Pathology at NYU Grossman School of Medicine. She holds a PhD from University College London. Her research focuses on genome integrity, genomics, immunology, stem cell biology, and systems biology, with particular emphasis on understanding how chromatin organization and epigenetic regulation influence cancer development and immune cell function.
Dr. Skok’s work explores the role of CTCF in chromatin architecture and its implications for gene regulation in health and disease. Her lab investigates mechanisms underlying genomic instability in cancers like glioblastoma and leukemia, as well as how chronic viral infections alter T cell function through subnuclear localization changes. She has pioneered computational tools such as MethNet for cancer data analysis and developed methods to predict 3D chromatin organization for genetic screening.
Her research publications span high-impact journals like Cell Genomics, Nature Communications, and Nature Biotechnology, with a focus on topics including CRISPR-based genomic screening, epigenetic biomarkers, and therapeutic resistance mechanisms. Though no formal awards are listed, her contributions to cancer genomics and molecular biology are widely recognized in the field.
Dr. Skok leads the Skok Lab, which integrates experimental and computational approaches to study genome organization and its functional consequences. Her work bridges basic science and clinical applications, addressing challenges in cancer treatment and immune system dynamics.
